Science Board to hear final CFSAN review
This article was originally published in The Tan Sheet
FDA's Science Board Nov. 15 reviews a subcommittee's final report on the Center for Food Safety and Applied Nutrition. Additionally, the board will hear an overview of CFSAN's strategic plan, the ongoing review of the Pharmacovigilance Program at the Center for Drug Evaluation and Research and strategic science plan, FDA said in a Oct. 25 Federal Register notice. Requests to make oral presentations must be submitted by Oct. 30. ..
You may also be interested in...
Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.
Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials.
US Ninth Circuit affirms a district court’s summary judgment in favor of Target and manufacturer of Up & Up brand biotin supplement it sells. Indian manufacturer targeted in putative class-action in New York prompted FDA’s 2016 creation of import alert category for Ayurvedic supplements.